Armen Asatryan, M.D., Chief Medical Officer  Wakefield, MA  (Private)  Virtual Presentation  Myrtelle is a gene therapy company focused on developing transformative treatments for neurodegenerative diseases. The company has a proprietary platform, intellectual property, and portfolio of programs and technologies supporting innovative gene therapy approaches for neurodegenerative diseases. Myrtelle has...

Jianjun Wang, Ph.D., Founder and Chief Scientist  Troy, Michigan  (Private)  Virtual Presentation  Qurgen gathers the world's top professional talents in iPS stem cells and the regenerative medical research field. The company is committed to establishing its stem cells technology platform and R&D and clinical translation based on its protein...

Adrienne Farid, Ph.D., Chief Operating Officer  Philadelphia, PA  (NASDAQ: IPSC)  Virtual Presentation  Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK...

Raja Sharif, CEO  London, UK  (Private)  Virtual Presentation  ATMPS is revolutionizing the delivery and administration of cell and gene therapies. Hataali, our technical platform, digitizes the vein-to-vein cell and gene therapy process, providing immutable digital records with full chain of custody, identity, and condition data using blockchain and IoT....

James Riddle, Vice President, Research Services & Strategic Consulting   Columbia Maryland   (Private)  Virtual Presentation  Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and...

Bethany Grant, Chief Technology Officer  Cambridge, MA  (Private)  Virtual Presentation  Kytopen, a spin-out of MIT, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which seamlessly links the discovery, development, and manufacturing phases of cell engineering. Flowfect®, a gentle, non-viral delivery method, unlocks new therapeutic...

Shin Hato, M.D., Ph.D., CEO  Tokyo, Japan  (Private)  Virtual Presentation  Cellusion is a regenerative medicine startup founded by three professors in Keio University’s School of Medicine, Department of Ophthalmology in Japan. Cellusion has several unique technologies including a highly efficient direct differentiation induction method to produce corneal endothelial substituted...

Scott Requadt, CEO  Louisville, KY  (NASDAQ: TALS)  Virtual Presentation  Talaris Therapeutics is a late clinical-stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing...

Michele Korfin, Chief Operating and Commercial Officer  Boston, MA  (NASDAQ: GMDA)  Virtual Presentation  Gamida Cell is developing a pipeline of advanced cell therapy candidates with the potential to provide a cure to patients across a range of diseases where there is an urgent medical need.   www.gamida-cell.com  ...

Flagg Flanagan, Chairman and CEO  Salt Lake City, UT  (Private)  Virtual Presentation  DiscGenics is a privately held, clinical-stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics’s first product candidate, IDCT (rebonuputemcel), is an allogeneic, injectable cell...

By using this website you agree to accept our Privacy Policy and Terms & Conditions